Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ciara M Kelly

Showing results (11-20 of 42) with videos related to

Pageof 5
Sort By:
Frontiers in Oncology|November 1, 2021
Case Report: Response to Regional Melphalan <i>via</i> Limb Infusion and Systemic PD1 Blockade in Recurrent Myxofibrosarcoma: A Report of 2 CasesEdmund K Bartlett, Sandra P D'Angelo, Ciara M Kelly, et al.
Cancer Medicine|June 4, 2021
Proton radiotherapy for recurrent or metastatic sarcoma with palliative quad shotAnna Lee, Jung J Kang, Havah Bernstein, et al.
Annals of Surgical Oncology|November 25, 2025
Outcomes of Patients Undergoing Sentinel Lymph Node Biopsy for Merkel Cell CarcinomaEdmund K Bartlett, Hannah L Kalvin, Christopher A Barker, et al.
NPJ Precision Oncology|March 25, 2025
Immunologic correlates in a CIC::DUX4 fusion-positive sarcoma responsive to dual immune checkpoint blockadeOlayode O Babatunde, Sara Coca Membribes, Cristina Anthonescu, et al.
Cancer Research Communications|March 17, 2023
Distinct IDH1/2-associated Methylation Profile and Enrichment of <i>TP53</i> and <i>TERT</i> Mutations Distinguish Dedifferentiated Chondrosarcoma from Conventional ChondrosarcomaJosephine Kam Tai Dermawan, Khedoujia Nafa, Abhinita Mohanty, et al.
Cancer Medicine|June 21, 2026
Concomitant Medication Effects on Immunotherapy Outcomes in Sarcoma: A Pooled Post Hoc Analysis of Seven Phase II TrialsAdel Shahnam, Kristen DiConza, Simran Jasnani, et al.
Investigational New Drugs|August 14, 2018
A phase Ib study of BGJ398, a pan-FGFR kinase inhibitor in combination with imatinib in patients with advanced gastrointestinal stromal tumorCiara M Kelly, Alexander N Shoushtari, Li-Xuan Qin, et al.
Cancers|July 26, 2020
Understanding and Attitudes toward Cancer Clinical Trials among Patients with a Cancer Diagnosis: National Study through Cancer Trials IrelandCathriona Kearns, Ronan Feighery, John Mc Caffrey, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 30, 2021
Long-term Follow-up and Patterns of Response, Progression, and Hyperprogression in Patients after PD-1 Blockade in Advanced SarcomaNicholas D Klemen, Sinchun Hwang, Martina Bradic, et al.
Journal for Immunotherapy of Cancer|April 2, 2022
Clinical, genomic, and transcriptomic correlates of response to immune checkpoint blockade-based therapy in a cohort of patients with angiosarcoma treated at a single centerEvan Rosenbaum, Cristina R Antonescu, Shaleigh Smith, et al.
Pageof 5

Showing results (11-20 of 42) with videos related to

Sort By:
Pageof 5
Frontiers in Oncology|November 1, 2021
Case Report: Response to Regional Melphalan <i>via</i> Limb Infusion and Systemic PD1 Blockade in Recurrent Myxofibrosarcoma: A Report of 2 CasesEdmund K Bartlett, Sandra P D'Angelo, Ciara M Kelly, et al.
Cancer Medicine|June 4, 2021
Proton radiotherapy for recurrent or metastatic sarcoma with palliative quad shotAnna Lee, Jung J Kang, Havah Bernstein, et al.
Annals of Surgical Oncology|November 25, 2025
Outcomes of Patients Undergoing Sentinel Lymph Node Biopsy for Merkel Cell CarcinomaEdmund K Bartlett, Hannah L Kalvin, Christopher A Barker, et al.
NPJ Precision Oncology|March 25, 2025
Immunologic correlates in a CIC::DUX4 fusion-positive sarcoma responsive to dual immune checkpoint blockadeOlayode O Babatunde, Sara Coca Membribes, Cristina Anthonescu, et al.
Cancer Research Communications|March 17, 2023
Distinct IDH1/2-associated Methylation Profile and Enrichment of <i>TP53</i> and <i>TERT</i> Mutations Distinguish Dedifferentiated Chondrosarcoma from Conventional ChondrosarcomaJosephine Kam Tai Dermawan, Khedoujia Nafa, Abhinita Mohanty, et al.
Cancer Medicine|June 21, 2026
Concomitant Medication Effects on Immunotherapy Outcomes in Sarcoma: A Pooled Post Hoc Analysis of Seven Phase II TrialsAdel Shahnam, Kristen DiConza, Simran Jasnani, et al.
Investigational New Drugs|August 14, 2018
A phase Ib study of BGJ398, a pan-FGFR kinase inhibitor in combination with imatinib in patients with advanced gastrointestinal stromal tumorCiara M Kelly, Alexander N Shoushtari, Li-Xuan Qin, et al.
Cancers|July 26, 2020
Understanding and Attitudes toward Cancer Clinical Trials among Patients with a Cancer Diagnosis: National Study through Cancer Trials IrelandCathriona Kearns, Ronan Feighery, John Mc Caffrey, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 30, 2021
Long-term Follow-up and Patterns of Response, Progression, and Hyperprogression in Patients after PD-1 Blockade in Advanced SarcomaNicholas D Klemen, Sinchun Hwang, Martina Bradic, et al.
Journal for Immunotherapy of Cancer|April 2, 2022
Clinical, genomic, and transcriptomic correlates of response to immune checkpoint blockade-based therapy in a cohort of patients with angiosarcoma treated at a single centerEvan Rosenbaum, Cristina R Antonescu, Shaleigh Smith, et al.
Pageof 5